Literature DB >> 23895036

A rare case of orbital haemangiopericytoma arising in childhood.

Anna M Rose1, Joy Kabiru, Geoffrey E Rose.   

Abstract

Haemangiopericytoma (HPC) is a rare soft tissue tumour of fibroblastic origin and is part of the solitary fibrous tumour spectrum. The tumour is generally considered to be benign, but can behave clinically as if sarcomatous -- with relentless infiltrative local growth. HPC generally presents in adulthood (median age 45 years for orbital disease) and is equally frequent in both sexes. HPC can arise in any site in the body and presents as a slowly growing, painless mass. We report a case of a 20 year old African male seen at Kikuyu Eye Unit, Kenya, with a 12 year history of a gradually enlarging, painless orbital mass. The patient underwent skin-sparing orbital exenteration with complete tumour excision; histology confirmed diagnosis of HPC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23895036     DOI: 10.3109/01676830.2013.815226

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  4 in total

1.  Orbit Solitary Fibrous Tumor: A Proposed Risk Prediction Model Based on a Case Series and Comprehensive Literature Review.

Authors:  Lester D R Thompson; Sofia S Liou; Kenneth A Feldman
Journal:  Head Neck Pathol       Date:  2020-06-11

Review 2.  A review of solitary fibrous tumours of the orbit and ocular adnexa.

Authors:  Cornelius René; Paolo Scollo; Dominic O'Donovan
Journal:  Eye (Lond)       Date:  2022-07-13       Impact factor: 4.456

Review 3.  Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review.

Authors:  Aleksandra Petrovic; Aurélie Obéric; Alexandre Moulin; Mehrad Hamedani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-13       Impact factor: 3.117

4.  Unusual occurrence of orbital hemangiopericytoma in the zygomatic bone of an adolescent: a case report.

Authors:  Bahram Eshraghi; Hadi Ghadimi; Zohreh Nozarian
Journal:  Eye Vis (Lond)       Date:  2018-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.